MAPK3 and depressive disorder: In a rat model of depression, apelin-13 treatment elicits antidepressant effect and improves recognition memory via activating phosphatidylinositol 3-kinases (PI3K) and extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathways.